STOCKHOLM - Cancer research or drugs treating cardiovascular illnesses could win a Nobel Prize on Oct 7 when a week of ...

Summit Therapeutics Inc. may have a potential successor to Merck's Keytruda with strong clinical data from China, but awaits ...

GlobalData’s report assesses the drugs in the Cathepsin L1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

TiumBio has dosed the first subject in its Phase II clinical trial of an oral immuno-oncology drug, TU2218, targeting ...

Healthcare drug developers have found that AI machine learning models have cut their discovery process down by 70% to 80%.

Apr. 10, 2024 — New research sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented ...

Prolactin is an important hormone in reproduction, pregnancy and childbirth. But could it also play a role in the development ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for ...

It said the drug did not 'achieve statistical significance' in terms of the survival rates of those suffering from breast ...

Rakovina Therapeutics is leveraging AI to accelerate the discovery of drug candidates for the treatment of cancer.